23 studies found for:    Open Studies | "Drug Hypersensitivity"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Management of Drug Hypersensitivity in Children
Condition: Drug Hypersensitivity
Intervention:
2 Unknown  Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions
Condition: Drug Hypersensitivity
Intervention: Drug: anti-TNF a
3 Recruiting Study of Omalizumab as Adjuvant Therapy in Chemotherapy Desensitization
Condition: Drug Allergy
Intervention: Drug: Omalizumab
4 Not yet recruiting Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study
Conditions: Adverse Drug Reaction;   Drug Allergy
Intervention:
5 Recruiting Quality of Life of Patients With a History of Drug Allergy in Thailand
Condition: Quality of Life
Intervention: Other: Questionnaires
6 Recruiting Comparison Between Corticosteroid and Topical Steroids in the DRESS
Condition: Drug Rash With Eosinophilia and Systemic Symptoms
Interventions: Drug: Prednisone;   Drug: Clobetasol
7 Recruiting The Diagnosis of Penicillin/Aminopenicillin Allergy in Thailand
Conditions: Penicillin Allergy;   Aminopenicillin Allergy
Intervention:
8 Recruiting Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis
Conditions: Chemical Injuries;   Unspecified Complication of Corneal Transplant;   Autoimmune Diseases;   Ocular Cicatricial Pemphigoid;   Stevens Johnson Syndrome;   Lupus Erythematosus, Systemic;   Rheumatoid Arthritis;   Other Autoimmune Diseases
Intervention: Drug: Riboflavin
9 Not yet recruiting The Use of Henna and Propolis on PPE
Condition: Palmar-plantar Erythrodysesthesia (PPE)
Interventions: Drug: Henna-Propolis;   Drug: Placebo
10 Recruiting Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)
Conditions: Stevens-Johnson Syndrome;   Corneal Blindness
Intervention: Drug: Infliximab
11 Unknown  A Randomized Trial to Determine if Vitamin B6 Can Prevent Hand and Foot Syndrome in Cancer Patients Treated With Capecitabine Chemotherapy
Condition: Hand and Foot Syndrome
Interventions: Drug: vitamin b6;   Drug: placebo
12 Unknown  Challenge Test for Acetylsalicylic Acid Hypersensitivity
Conditions: Asthma Aspirin-sensitive;   ASA Intolerant Asthma;   Asthma, Aspirin-Induced;   Asthma, Nasal Polyps, and Aspirin Intolerance
Interventions: Drug: Acetylsalicylate;   Drug: Isotonic NaCl
13 Unknown  Prevention of Capecitabine Induced Hand and Foot Syndrome
Condition: Cancer
Intervention: Device: socks containing copper-oxide fibers
14 Unknown  Ciclosporin in the Management of New Erythema Nodosum Leprosum
Condition: Leprosy
Interventions: Drug: Ciclosporin;   Drug: prednisolone
15 Unknown  Ciclosporin in the Management of Chronic or Recurrent Erythema Nodosum Leprosum
Condition: Leprosy
Interventions: Drug: prednisolone;   Drug: ciclosporin
16 Recruiting Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
Conditions: Other Specified Inflammatory Disorders of Skin or Subcutaneous Tissue;   Pyoderma Gangrenosum;   Erosive Pustular Dermatosis of the Scalp;   Sweet's Syndrome;   Behcet's Disease;   Bowel-associated Dermatosis-arthritis Syndrome;   Pustular Psoriasis;   Acute Generalized Exanthematous Pustulosis;   Keratoderma Blenorrhagicum;   Sneddon-Wilkinson Disease;   IgA Pemphigus;   Amicrobial Pustulosis of the Folds;   Infantile Acropustulosis;   Transient Neonatal Pustulosis;   Neutrophilic Eccrine Hidradenitis;   Rheumatoid Neutrophilic Dermatitis;   Neutrophilic Urticaria;   Still's Disease;   Erythema Marginatum;   Unclassified Periodic Fever Syndromes / Autoinflammatory Syndromes;   Dermatitis Herpetiformis;   Linear IgA Bullous Dermatosis;   Bullous Systemic Lupus Erythematosus;   Inflammatory Epidermolysis Bullosa Aquisita;   Neutrophilic Dermatosis of the Dorsal Hands (Pustular Vasculitis);   Small Vessel Vasculitis Including Urticarial Vasculitis;   Erythema Elevatum Diutinum;   Medium Vessel Vasculitis
Intervention: Procedure: Collection of biological samples
17 Recruiting Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin)
Conditions: Asthma, Aspirin-Induced;   Aspirin Exacerbated Asthma
Intervention: Drug: Prasugrel
18 Unknown  Study of 0.1% Uracil Ointment (1UO) Ointment for the Prevention of Hand-Foot Syndrome
Conditions: Palmar-Plantar Erythrodysesthesia;   Breast Cancer
Interventions: Drug: Ointment;   Drug: 0.1% Uracil Ointment
19 Not yet recruiting Topical Infliximab in Autoimmune Eyes With Keratoprosthesis
Conditions: Stevens-Johnson Syndrome;   Toxic Epidermal Necrolysis (Lyell) Syndrome;   Mucous Membrane Pemphigoid
Intervention: Drug: topical infliximab
20 Recruiting Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer
Conditions: Chemotherapeutic Agent Toxicity;   Dermatologic Complications;   Palmar-plantar Erythrodysesthesia;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Dietary Supplement: pyridoxine hydrochloride;   Drug: capecitabine;   Procedure: complementary or alternative medicine procedure

Previous Page Studies Shown (1-20) Next Page (21-23) Show next page of results
Indicates status has not been verified in more than two years